Skip to main content
. 2021 Nov 11;94(3):1138–1145. doi: 10.1002/jmv.27435

Table 1.

Baseline characteristics of participants underwent COVID‐19 test with and without heart failure before and after propensity score matching

Variable Before propensity score matching After propensity score matching SMD*
Without HF With HF Without HF With HF
N 195,811 14,923 41,150 14,080
Sex, male 91,338 (46.65) 7606 (50.97) 20,788 (50.52) 7179 (50.99) 0.0041
Age (years) 0.0138
<60 138,336 (70.65) 2424 (16.24) 8279 (20.12) 2421 (17.19)
≥60 57,475 (29.35) 12,499 (83.76) 32,871 (79.88) 11,659 (82.81)
Household income −0.0312
T1, lowest 65,558 (33.48) 5931 (39.74) 16,178 (39.31) 5777 (41.03)
T2 66,665 (34.05) 3742 (25.08) 10,780 (26.20) 3606 (25.61)
T3, highest 63,588 (32.47) 5250 (35.18) 14,192 (34.49) 4697 (33.36)
Comorbidities
Hypertension 50,628 (25.86) 13,846 (92.78) 37,068 (90.08) 13,003 (92.35) 0.0038
Diabetes mellitus 22,448 (11.46) 6074 (40.70) 15,173 (36.87) 5761 (40.92) 0.0022
Stroke 8673 (4.43) 2765 (18.53) 6404 (15.56) 2621 (18.62) −0.0042
Atrial fibrillation 3266 (1.67) 3985 (26.70) 3007 (7.31) 3157 (22.42) −0.0450
Asthma 11,869 (6.06) 2590 (17.36) 5342 (12.98) 2433 (17.28) −0.0034
Chronic kidney disease 13,698 (7.00) 5485 (36.76) 10,323 (25.09) 4962 (35.24) −0.0068
Malignancy 29,210 (14.92) 4379 (29.34) 12,044 (29.27) 4177 (29.67) 0.0082
COVID‐19
Unadjusted Ref 0.55 [0.49‐0.61] Ref 0.85 [0.70‐0.97] 0.013**
Sex and age adjusted Ref 0.60 [0.54‐0.68] Ref 0.85 [0.70‐0.96] 0.011**
Fully adjusted Ref 0.82 [0.72‐0.93] Ref 0.91 [0.79‐1.04] 0.146**

Note: Data are presented as number with percentage.

Abbreviations: HF, heart failure; SMD, standard mean difference; T, tertile.

*

All standardized mean difference values were <0.1 in the propensity score matched cohort.

**

p value for odds ratio.